# Sodium Fluoride F 18

NDC: 24562-002
Generic name: SODIUM FLUORIDE F-18
Labeler / Manufacturer: Biomedical Research Foundation of Northwest Louisiana
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20150122

FDA application: ANDA204351

## Active ingredients

- SODIUM FLUORIDE F-18: 200 mCi/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"24562-002"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=24562-002
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4c45fe05-e3b7-4383-966c-4e218ff6f94a